Locate Bio’s Osteomyelitis Implant Gets FDA Breakthrough Device Designation

Orthobiologics company Locate Bio has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for CognitOss, a treatment it is developing for chronic osteomyelitis.